Arrowhead Pharmaceuticals
Large Cap · Healthcare · Biotechnology
$86.68+$1.09 (+1.27%)
Arrowhead Pharmaceuticals
Large Cap · Healthcare · Biotechnology
$86.68+$1.09 (+1.27%)
Stock analysis
Get the AI take on ARWR
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$14.30
High$87.83
Today $86.68
RSI (14)
54.8Neutral
03070100
Overall score
37/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Current price
$86.68
Lowest
$100
Median target
$104
Highest
$126
LowHigh
Operating Record
Revenue
What's working
- Cash exceeds debt by $218.5M, leaving a net cash buffer, a good sign.
- Current ratio: What's on hand comfortably covers the bills due over the next year.
What to watch
- Price / sales: Revenue alone can't justify this price; profits need to catch up fast.
- ROIC: Capital plowed back into the business isn't earning much for its trouble.
What the market charges
Forward P/E
No signal · Not enough data to judge
-
Price / sales
Rich · Priced well above what its revenue alone supports
18.28x
Price / FCF
No signal · Not enough data to judge
-
EV / EBITDA
No signal · Not enough data to judge
-
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
-101.1%
ROE
Needs attention · Unfavorable
-55.2%
Debt / equity
Needs attention · Unfavorable
2.96x
Current ratio
Strong · Comfortable room to cover bills due within a year
5.90x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $12.24B | - | +16.8% | 37 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |